Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Claridgeon Jun 15, 2019 3:15pm
62 Views
Post# 29829182

RE:RE:RE:RE:RE:RE:RE:RE:RE:200,000 Warrants Converted

RE:RE:RE:RE:RE:RE:RE:RE:RE:200,000 Warrants ConvertedBionicblowjob is always betting that things will never happen because they haven't heppened yet.

Strategy of a "fear mongering" basher to create a doubt.

Like this statement, BJB is telling us that more efficacy data than just 2 patients won't spike the share price.  And he knows more than Dr. Jewett about a need or not for a Ph. 3!!! lolll 

Hey BJB, what's your ground and sources regarding your 2 points?  

You recently stated that the sp will take off once the 3 month data from the phase 2 trial is released. I don't see that happening since it has already been acertained in the phase 1b trial that efficacy can be expected at the 3 month juncture. As for whether the FDA will require a phase 3 trial, who knows for sure?

It's only your "opinion" of a paid basher.  Your track record over the last 5 years has been 0% as you called a failure of TLT's technology and finances on all fronts.

Why again are you focused on a science stock, you the agnostic to science, as per your own saying?

And why did you come back on this board?  Your retirement is boring to that point?  
Bullboard Posts